(Q46825545)

English

Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml? (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

computed tomography

1 reference

based on heuristic

inferred from title

author name string

Martin Heinisch

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

Albert Dirisamer

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

Wolfgang Loidl

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

Franz Stoiber

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

Bernhard Gruy

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

Silke Haim

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

Werner Langsteger

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

Molecular Imaging and Biology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

43-48

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

https://scigraph.springernature.com/pub.10.1007/s11307-005-0023-2

0 references

Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings

1 reference

https://api.crossref.org/works/10.1007%2FS11307-005-0023-2

21 January 2018

Elevated phosphocholine concentration in ras-transformed NIH 3T3 cells arises from increased choline kinase activity, not from phosphatidylcholine breakdown

1 reference

https://api.crossref.org/works/10.1007%2FS11307-005-0023-2

21 January 2018

Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Is Useless for the Detection of Local Recurrence after Radical Prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of endorectal coil versus body coil MRI for diagnosis of recurrent pelvic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of metastatic disease in men with biochemical failure following radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate specific antigen only progression of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

9:30-9:45. Preliminary Evaluation of F-18 Fluorocholine (FCH) as a PET Tumor Imaging Agent.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of [(18)F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and radiation dosimetry of 18F-fluorocholine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET and PET-CT for evaluation of colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

16. FDG-PET in the Detection of Recurrence in Colorectal Cancer Based on Rising CEA Level. Experience in 72 Patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of CA 125 and CEA levels on the results of (18)F-deoxyglucose positron emission tomography in suspected recurrence of epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results

1 reference

https://pubmed.ncbi.nlm.nih.gov/16315004

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11307-005-0023-2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16315004

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46825545&oldid=1550121809"